Lamotrigine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 33 USDMF, 21 CEP/COS, 5 JDMF, 22 EU WC, 9 KDMF, 22 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1083 FDF Dossiers, 230 FDA Orange Book, 597 Europe, 38 Canada, 66 Australia, 80 South Africa, 72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 150MG, TABLET;ORAL - 200MG, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 10 Evonik, 5 Rochem International Inc, 23 SPI Pharma, 8 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 9 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 1 Zeal MediPharma, 1 ACG Worldwide, 8 Actylis, 3 Aeon Procare, 4 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 38 BASF, 1 Bioplus Life Sciences, 1 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 4 Doshion Polyscience, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 12 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 40 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 9 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 14 Seppic, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

101 Fillers, Diluents & Binders, 82 Coating Systems & Additives, 50 Disintegrants & Superdisintegrants, 47 Direct Compression, 45 Controlled & Modified Release, 44 Taste Masking, 34 Granulation, 33 Solubilizers, 29 Thickeners and Stabilizers, 25 Lubricants & Glidants, 25 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 17 Parenteral, 15 Topical, 7 API Stability Enhancers, 7 Emulsifying Agents, 7 Rheology Modifiers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

42 News #PharmaBuzz

42 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 225 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

10 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 1 USP, 12 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Alembic gains FDA approval for Lamotrigine Extended-Release Tablets

04 Oct 2024

// EXPRESSPHARMA

Alembic Gains USFDA Approval For Lamotrigine Extended-Release

03 Oct 2024

// EXPRESSPHARMA

Alembic`s Generics Lamotrigine Receives Approval in US

01 Oct 2024

// FDA

GSK to cut US prices for Advair, Valtrex and Lamictal

23 Dec 2023

// REUTERS

Enforcement Report - Week of August 17, 2022

17 Aug 2022

// FDA

U.S. FDA declines to approve Eton Pharma's anti-seizure drug

28 May 2022

// B. Satija REUTERS

Lamotrigine

Lamotrigine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

68 API Suppliers

33 USDMF

21 CEP/COS

5 JDMF

22 EU WC

9 KDMF

22 NDC API

39 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1083 FDF Dossiers

230 FDA Orange Book

597 Europe

38 Canada

66 Australia

80 South Africa

72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG

TABLET;ORAL - 150MG

TABLET;ORAL - 200MG

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 25MG

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

10 Evonik

5 Rochem International Inc

23 SPI Pharma

8 DKSH

1 Pharm-RX Chemical

8 Faran Shimi Pharmaceutical

10 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

9 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Pfanstiehl

1 Pramukh Pharmachem

1 Zeal MediPharma

1 ACG Worldwide

8 Actylis

3 Aeon Procare

4 Alcedo Pharmachem

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

38 BASF

1 Bioplus Life Sciences

1 Clariant

16 Corel Pharma Chem

7 DFE Pharma

4 Doshion Polyscience

1 Finar

13 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

12 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

40 Kerry

3 Kima Chemical

6 Lonza Capsugel

20 Microlex e.U

1 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

5 Novo Excipients

5 Pharmatrans-Sanaq

9 Pluviaendo

5 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

23 Roquette

TABLET;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons